Please reload

Recent Posts

ManGraDex Graphene-Based MRI Contrast Agent Featured in Graphene Investor

December 28, 2016

 

Graphene Innovation Investment Fund (Graphene-Invester.com) featured Theragnostic Technologies Graphene-Based MRI Contrast Agent in the article "How Graphene-Based Contrast Agents Improbe MRI Scans". 

"MRI scans, which generate images of the inside of the body, are important tools when it comes to testing, diagnosing, and detecting internal abnormalities. MRIs sometimes use contrast agents to improve visibility, which, though mostly safe and effective, remain imperfect.

 

Enter graphene. As it seems with so many areas of science, the inclusion of this atom-thin carbon sheet has the potential to radically improve MRIs—and contrast agents in particular. According to a paper published in the journal Particle and Particle Systems Characterization, discs of graphene called nanoparticles could be used to target specific kinds of tissues during MRI scans."

 

READ FULL ARTICLE

 

 

Please reload

© Theragnostic Technologies, Inc. 2019

 info@theragnostictechnologies.com

* Disclaimer:  Our products and technologies are currently not available for clinical use. FDA or other regulatory agencies have not evaluated the statements on this website regarding our products and technologies.